Cloning and characterization of a novel member of the transforming growth factor-beta/bone morphogenetic protein family.
Members of the transforming growth factor-beta (TGF-beta) superfamily of growth and differentiation factors have been identified in a wide variety of organisms, ranging from invertebrates to mammals. Bone morphogenetic proteins (BMPs) constitute a subgroup of proteins belonging to the TGF-beta superfamily. BMPs were initially identified by their ability to induce endochondral bone formation at ectopic sites, suggesting a critical role for this family in development and regeneration of the skeleton. They are also expressed at a variety of nonskeletal sites during development, suggesting possible extraskeletal roles for these proteins. We cloned a novel member of the BMP family that is expressed at high levels in the placenta and the prostate and that we have designated as prostate-derived factor (PDF). Based on cDNA sequence analysis, the predicted PDF protein contains two cysteines in addition to the seven conserved cysteines that are the hallmark of the members of the TGF-beta superfamily. In addition, Northern blot hybridization to poly(A)+ RNA showed low levels of expression in the kidney and pancreas. We further characterized the expression of this member of the BMP family by in situ hybridization and immunohistochemistry. These results show high expression in the terminal villae of the placenta. The expression of the protein as visualized by immunohistochemistry shows an expression pattern identical to that of the message in the terminal villae of the placenta. In day 18 rat embryos, protein expression was also seen in the skin and in the cartilaginous tissue of developing skeleton. Orchidectomy and dihydrotestosterone treatment of rats revealed that PDF expression is regulated by androgens in the prostate. In addition, subcutaneous implantation of recombinant PDF induced cartilage formation and the early stages of endochondral bone formation. These data indicate that PDF has a functional relationship to the BMPs.
Paralkar
V M
VM
Department of Metabolic Diseases, Central Research Division, Pfizer, Inc., Groton, Connecticut 06340, USA. Vishwas_M_Paralkar@groton.pfizer.com
Vail
A L
AL
Grasser
W A
WA
Brown
T A
TA
Xu
H
H
Vukicevic
S
S
Ke
H Z
HZ
Qi
H
H
Owen
T A
TA
Thompson
D D
DD
D000595:Amino Acid Sequence; D000728:Androgens / Q000502:physiology; D000818:Animals; D001483:Base Sequence; D015152:Blotting, Northern; D019485:Bone Morphogenetic Proteins / Q000235:genetics*; D002460:Cell Line; D003001:Cloning, Molecular; D018076:DNA, Complementary; D005786:Gene Expression Regulation / Q000502:physiology; D055436:Growth Differentiation Factor 15; D008297:Male; D008565:Membrane Proteins / Q000235:genetics* / Q000378:metabolism; D008907:Mink; D008969:Molecular Sequence Data; D009919:Orchiectomy; D051381:Rats; D017386:Sequence Homology, Amino Acid; D015398:Signal Transduction; D016212:Transforming Growth Factor beta / Q000235:genetics*
D000728:Androgens; D019485:Bone Morphogenetic Proteins; D018076:DNA, Complementary; C526142:Gdf15 protein, rat; D055436:Growth Differentiation Factor 15; D008565:Membrane Proteins; D016212:Transforming Growth Factor beta